- Investor's Business Daily•15 hours ago
Biogen stock underplayed promising Alzheimer's Disease drug results on investor concern over a patient seizure.
- Investor's Business Daily•3 days ago
European, Japanese or specialty pharma could look to acquire Ariad as it rapidly closes in on approval of a lung cancer drug, RBC says.
- Investor's Business Daily•4 days ago
Sanofi is mulling a bid for Actelion, which has an offer from Johnson & Johnson on the table.
RHHBY : Summary for ROCHE HLDGS AG SPN ADR EACH REP - Yahoo Finance
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||27.59 - 27.94|
|52 Week Range||25.25 - 35.13|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.50|
|Dividend & Yield||1.02 (3.67%)|
|1y Target Est||N/A|